Compare Monolithic Power Systems Inc (MPWR) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monolithic Power Systems Inc vs Pfizer Inc — how do they compare? Monolithic Power Systems Inc trades at $1,381.5 (market cap $65.28B), while Pfizer Inc trades at $24.92 (market cap $141.06B). The key difference: Pfizer Inc is far larger — about 2.2× Monolithic Power Systems Inc's market cap, and Pfizer Inc pays the higher dividend (6.95%). Which is the better fit depends on your goals.
| MPWR | PFE | |
|---|---|---|
Market Cap | $65.28B | $141.06B |
Sector | Utilities | Health |
52-Week High | $1.69K | $28.56 |
52-Week Low | $711.24 | $23.29 |
Enterprise Value | $63.94B | $191.72B |
Dividend Yield | 0.6% | 6.95% |
Volume | — | 29,869,932 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPWR trades at $1,328.80, up 1.28% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 22.98% net margin and robust cash flow, but carries high valuation multiples like a P/E of 93.92. Analyst consensus is overwhelmingly bullish with an $1,810 price target, though news includes both AI infrastructure optimism and legal investigations.
Outlook remains positive given earnings momentum and AI-driven demand, but risks include stretched valuations and ongoing legal scrutiny. The stock offers growth exposure but requires monitoring of execution and market sentiment shifts.
Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.
The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
